PRN Meeting: December 14, 2022 Jointly provided by the Medical Society of the State of New York, at a Zoom webinar, 7:00 p.m. to 9:00 p.m (EST).

Target Audience:

Physicians, Nurse Practitioners, and Physician Assistants caring for people at risk for, or infected with HIV and/or viral hepatitis.

Course Director: James F. Braun, DO, President, Physicians' Research Network

Moderator: Joseph P. McGowan, MD, FIDSA, FACP, AAHIVS , Professor, Institute of Health System Science, Feinstein Institutes for Medical Research

Guest Speakers and Presentations:

Highlights from HIV Glasgow 2022: What Was New and Exciting?

Jürgen Rockstroh, MD

Head of Infectious Diseases
University Hospital Bonn
Bonn, Germany

At the completion of this program, participants will:
1. TBD
2. TBD
3. TBD

How to Manage a Pandemic: Science, Public Health and Culture

William M. Valenti, MD

Senior Vice President for Strategic Advancement
Chief of Innovation, Co-Founder, and Staff Physician
Trillium Health, Rochester, NY

At the completion of this program, participants will:
1. Appreciate similarities and differences between HIV, COVID 19 and Monkeypox.
2. Be able to discuss epidemiologic tools to describe epidemics, pandemics and outbreaks.
3. Review preparedness for and responses to current and future epidemics, pandemics and outbreaks.

Accreditation Statement: This activity has been planned and implemented in accordance with the Accreditation Requirements and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). The Medical Society of the State of New York (MSSNY) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing Medical Education for physicians.

The Medical Society of the State of New York (MSSNY) designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclosure Statement:

As an ACCME-accredited provider, MSSNY is required to identify and mitigate relevant financial relationships of all individuals in control of CME content. Financial relationships are relevant if the following three conditions are met for the prospective person who will control content of the education: A financial relationship, in any amount, exists between the person in control of content and an ineligible company; The financial relationship existed during the past 24 months; The content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Dr. James F. Braun (Planner/Course Director/ Moderator) has no relevant financial relationships to disclose. Dr. Joseph P. McGowan (Moderator) has no relevant financial relationships to disclose. Dr. William M. Valenti (Presenter) has had the following personal financial relationships in the past 24 months with manufacturers of the products or services that may be presented in this CME activity: Research grants from: ViiV and Gilead; Speaker to ViiV. Dr. Valenti submitted their slides in advance for adequate peer review and will support their presentation and clinical recommendations with the best available evidence from the medical literature. All relevant financial relationships have been mitigated. Dr. Jürgen Rockstroh (Presenter) has had the following personal financial relationships in the past 24 months with manufacturers of the products or services that may be presented in this CME activity: DSMB Member with: Abivax, and Galapagos; Consultant to: Boehringer; Advisory Board Member to: Merck, Gilead, and ViiV; Speaker at: Merck, Gilead, ViiV, and Theratechnologies. Dr. Rockstroh submitted their slides in advance for adequate peer review and will support their presentation and clinical recommendations with the best available evidence from the medical literature. All relevant financial relationships have been mitigated.

Financial Support:

This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare